Skip to content
Main Navigation
CDMO Services
Services overview
Platform Leadership
Extensive Expertise
Case Studies
Manufacturing Infrastructure
Infrastructure Overview
Facilities by project stage
News
News Releases
OmniaBio in the News
Recent Highlights
Events
Careers
Contact Us
Mailing list
OmniaBio Inc. announces private investor.
Posted on
December 1, 2022
by
jpearl
Post navigation
NGen Supports Commercial Scale Manufacturing of Cell and Gene Therapies in Canada.
Funding from Ontario Government for OmniaBio.